VILLA, Federico
 Distribuzione geografica
Continente #
EU - Europa 195
AS - Asia 137
NA - Nord America 110
SA - Sud America 11
AF - Africa 7
Totale 460
Nazione #
US - Stati Uniti d'America 104
IT - Italia 75
RU - Federazione Russa 52
SG - Singapore 43
CN - Cina 36
HK - Hong Kong 21
IN - India 18
IE - Irlanda 15
DE - Germania 14
FR - Francia 13
BR - Brasile 11
VN - Vietnam 10
GB - Regno Unito 6
BJ - Benin 4
CA - Canada 4
ES - Italia 4
JP - Giappone 3
KR - Corea 3
PT - Portogallo 3
AT - Austria 2
FI - Finlandia 2
MX - Messico 2
NL - Olanda 2
PK - Pakistan 2
RO - Romania 2
SE - Svezia 2
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
JO - Giordania 1
LT - Lituania 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 460
Città #
Milan 31
Singapore 22
Hong Kong 21
Dublin 15
San Jose 15
Beijing 13
Ashburn 10
Novara 9
Moscow 8
Los Angeles 7
Albuquerque 6
Cenon 6
Bari 5
Mumbai 5
Cagliari 4
Canelli 4
Cotonou 4
Falkenstein 4
Frankfurt am Main 4
Paris 4
Turin 4
Buffalo 3
Council Bluffs 3
Ho Chi Minh City 3
Porto 3
Pune 3
Redondo Beach 3
Rome 3
Seoul 3
Bengaluru 2
Boardman 2
Chennai 2
Denver 2
Gandhinagar 2
Guangzhou 2
Helsinki 2
Iași 2
Lauterbourg 2
New York 2
Nuremberg 2
Orem 2
Pettinengo 2
Philadelphia 2
Santa Clara 2
Southwark 2
São Paulo 2
Tokyo 2
Vienna 2
Vijayawada 2
Zaozhuang 2
Addis Ababa 1
Amman 1
Amsterdam 1
Angra dos Reis 1
Bordj Bou Arreridj 1
Boston 1
Charlotte 1
Da Nang 1
Fortaleza 1
Gravataí 1
Greensboro 1
Haiphong 1
Hanoi 1
Huntington Beach 1
Ipaussu 1
Jinan 1
Johannesburg 1
Lahore 1
London 1
Madrid 1
Manassas 1
Mexico City 1
Montreal 1
Monza 1
Munich 1
Narashino Shi 1
Nova Iguaçu 1
Pasadena 1
Phoenix 1
Poplar 1
Pýrgos 1
Querétaro 1
Rio de Janeiro 1
Santa Ana 1
Santa Fe 1
Santa Maria de Jetibá 1
Stockholm 1
Stony Mountain 1
São Francisco de Paula 1
Toronto 1
Udupi 1
Vilnius 1
Wenzhou 1
Zhoukou 1
Totale 311
Nome #
The determinants of market access for medicines: theoretical issues and empirical evidence 165
Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement) 75
Variables affecting pricing of orphan drugs: the Italian case 64
Monitoring the community use of antibiotics in Italy within the National Action Plan on antimicrobial resistance 61
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency 53
Establishing the value of new drugs in Italy 52
Totale 470
Categoria #
all - tutte 2.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202323 0 0 0 0 0 0 2 1 14 1 4 1
2023/202475 7 1 16 7 6 2 3 4 0 0 18 11
2024/2025117 1 1 6 5 6 3 12 36 17 10 5 15
2025/2026255 5 19 14 40 40 11 38 43 28 17 0 0
Totale 470